Ascendia

  MARKET NEWS

Allarity Therapeutics Doses First Patient in Phase 1b Clinical Trial Evaluating Dovitinib & Stenoparib Combination in Advanced Solid Tumors
Synlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) Annual Meeting
Enlivex Receives Positive DSMB Recommendation & IMOH Clearance to Continue Phase 1/2 Trial
Bhami Research Laboratory & Catalent Enter Licensing Agreement for Technology to Deliver High-Concentration Biologics Subcutaneously
Jubilant HollisterStier Announces New President & Upcoming Availability of Expanded Production Capacity for Sterile Injectables
Gerresheimer Announces Successful FDA Inspection at Peachtree City Site

  FEATURED EDITORIAL

  COMPANY PROFILE

Fortis Life Sciences offers world-class reagents, tools, materials, and custom services with a best-in-class customer experience for our customers in the biopharma industry. Through our brand nanoComposix, we provide precisely engineered and highly characterized nanomaterials to a global customer base. nanoComposix is an ISO 13485 (2016)-Certified*, FDA-registered developer and contract manufacturer with a nanomaterial product portfolio containing hundreds of variants engineered to address the unique challenges presented by our customers. Our products and CDMO services are backed by technical teams with extensive expertise in nanotechnology, biology, chemistry, physics, and optics. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Hovione & Ripple Enter Strategic Partnership to Expand Epidel Platform Into Non-Ophthalmic Space

Hovione & Ripple Enter Strategic Partnership to Expand Epidel Platform Into Non-Ophthalmic Space

Hovione and Ripple Therapeutics have entered a strategic partnership to expand the use of Ripple’s Epidel® platform beyond ophthalmic applications….

Owlstone Medical Enters Partnership With Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection

Owlstone Medical Enters Partnership With Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection

Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, recently announced it has entered into a Research Agreement with Bicycle Therapeutics plc, a biotechnology company pioneering a new….

Pfizer Invests  Billion in Seagen Acquisition to Battle Cancer

Pfizer Invests $43 Billion in Seagen Acquisition to Battle Cancer

Pfizer Inc. and Seagen Inc. recently announced they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology company that discovers, develops, and commercializes transformative cancer medicines, for $229 in cash….

Nemera & Nelson Labs Europe Strengthen Partnership to Offer Integrated Services to Customers

Nemera & Nelson Labs Europe Strengthen Partnership to Offer Integrated Services to Customers

This strategic alliance will give a unique advantage to pharmaceutical & bio-tech customers – accelerating the go-to-market of their drug-device combination products by offering analytical chemistry, drug compatibility lab testing and expert advice….

  WHITEPAPERS & WEBINARS

WEBINAR - Step Into the Future of Therapeutic Antibody Discovery

WEBINAR - Step Into the Future of Therapeutic Antibody Discovery

Join us to hear about our new biotherapeutic antibody discovery service — the Pioneer Platform, and how it can help you find your next lead candidate.

  WHITEPAPERS & WEBINARS

WHITEPAPER - Improve Process Economics & Enable High Protein Concentrations

WHITEPAPER - Improve Process Economics & Enable High Protein Concentrations

This white paper evaluates the effect of the excipients in the Viscosity Reduction Platform on ultrafiltration processes used to produce a highly concentrated formulation of a monoclonal antibody (mAb). Two filtration methods are demonstrated in this work.

Click here to …

WHITEPAPER - Purity is Paramount: Assessing N-Oxide Impurities in Lipids Used in Lipid Nanoparticle Delivery Systems

WHITEPAPER - Purity is Paramount: Assessing N-Oxide Impurities in Lipids Used in Lipid Nanoparticle Delivery Systems

By: Sabrina Metze, PhD, Ulrich Klöckner, PhD, Lars Geiger, PhD, Justin Schieven, PhD, and Thomas Böhmer*

Summary

The quality of lipids in a lipid nanoparticle assembly is critically important to the functionality of mRNA-based therapeutics. Packer et al. have identified …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

March 29 – Prefilled Syringes
April 5 – Inhalation Drug Delivery